In preclinical studies, BPC-157 has shown to have a positive impact when treating conditions such as inflammatory bowel disease, traumatic brain injury, and arthritis [5]
CellGenic products are intended for qualified researchers, laboratories, and professional scientific applications
Shaking the Vial During Reconstitution Vigorous shaking denatures peptides by introducing air bubbles and mechanical stress on the peptide structure
the only ASV identified for Staphylococcus mapped to Staphylococcus xylosus , and the only ASV found for UBA1819 mapped to Ruthenibacterium lactatiformans
Conditions that affect the stomach lining, such as atrophic gastritis, reduce intrinsic factor production
A GRAS determination reflects a safety conclusion for a described food-ingredient use